NEWS

WIRES

OTHER

Atherotech Diagnostics Lab Showcases VAP Cholesterol Test at Pri-Med South 2011 Conference

The annual regional meeting will be held February 11-13 at the Broward County Convention Center in Fort Lauderdale, Fla., and explores the latest research, technology and ideas in primary care medicine.

Atherotech representatives will be available to discuss new clinical publications, the patented VAP Cholesterol Test and cardiometabolic test options throughout the Pri-Med gatherings. Blood draws will be provided to qualified attendees during regular exhibit hours. Unlike the standard lipid profile, the VAP Test directly measures LDL; therefore, fasting is not required.

"Using the detailed lipid profiles in the VAP Cholesterol Test, we can identify Lp(a) and other added risk that goes far beyond the capabilities of the standard lipid profile," said Michael E. Cobble, M.D., Atherotech's Chief Medical Officer and author of the online lipid discussion at www.CobblesCorner.com. "Pri-Med attendees should line up early to get their VAP advanced lipid profile and learn how to achieve better outcomes for their patients, and maybe even themselves."

Atherotech's VAP Test is the only expanded lipid test that routinely reports directly measured LDLc, which is included in the 22 reported cholesterol components - all at no additional cost. These components include Lp(a), apoB, apoA1, and the apoB/apoA1 ratio, making the VAP Test the only lipid profile that routinely reports all three lipid parameters - LDL, non-HDL and apoB - considered necessary by the American Diabetes Association and American College of Cardiology. The comprehensive lipid profile also identifies markers of metabolic syndrome, often associated with early diabetes.

Atherotech provides clinicians with a single source for the VAP Cholesterol Test and more than a dozen cardiovascular and metabolic tests, including C-Reactive Protein (hsCRP), LpPLA2, apoE genotype, NT-proBNP, Cystatin-C, T3 and T4 when TSH is abnormal, plus gamma-glutamyl transferase (GGT), a recognized cardiovascular risk biomarker.

Get updates throughout the conference by following @Atherotech and @PriMed_Alerts on Twitter. For more information, visit www.atherotech.com or call 877.901.8510.

About Atherotech Diagnostics Lab

Atherotech is a CLIA-certified clinical reference laboratory and cardiodiagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP Test is the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for direct LDL measurement, which is accurate with non-fasting samples. The VAP Test is available through national and regional diagnostic laboratories and is reimbursed by many of the largest private insurers as well as Medicare. For more information, visit www.atherotech.com.

Armada Medical Marketing for Atherotech
Micki Sievwright, 303-623-1190 x240
micki@armadamedical.com